SAN DIEGO, Oct. 19 /PRNewswire-FirstCall/ — Aethlon Medical,
Inc. (OTC Bulletin Board:
AEMD), the pioneer in developing therapeutic filtration devices
to address infectious disease and cancer, announced today that Rod
Kenley has been appointed to the Aethlon Medical board of
directors.
(Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)
(Photo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)
Mr. Kenley has 33 years of experience in healthcare, most of
which have been spent in the extracorporeal blood purification
arena. Mr. Kenley held several positions at Baxter Healthcare
(Travenol) from 1977 through 1990 including International Marketing
Manager, Business Unit Manager for Peritoneal and Hemodialysis
products, Manager of New Business Development, Director of
Worldwide Product Planning, Director of Advanced Product
Development, and VP of Electronic Drug Infusion. During this tenure
he conceived of and managed the launch of several new products that
have been highly commercially successful including the HomeChoice
peritoneal dialysis cycler.
Mr. Kenley founded Aksys Ltd. in January 1991 to develop and
commercialize his concept of a daily home hemodialysis system which
was commercially launched in 2002 as the PHD system. In 2004, Mr.
Kenley initiated the development of a second generation home
hemodialysis system in partnership with DEKA Research &
Development Corporation in Manchester New Hampshire. In 2007, the
assets of Aksys Ltd. were acquired by DEKA where Mr. Kenley is now
employed and continues work on the second generation home HD system
along with several other new dialysis products.
Mr. Kenley is the recipient of over 30 patents and has been a
frequent presenter at
‘/>”/>
SOURCE